ClinicalTrials.Veeva

Menu

Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy

A

Ain Shams University

Status

Unknown

Conditions

Nulliparity

Treatments

Drug: Diclofenac
Drug: Lidocaine Hydrochloride

Study type

Interventional

Funder types

Other

Identifiers

NCT03298646
Hysteroscopy

Details and patient eligibility

About

Lidocaine Infusion On Hysteroscopic Media Versus Oral Diclofinac For Pain Relief During Outpatient Hysteroscopy. A Randomized Controlled Trial.

Full description

10 ml of 2% lidocaine hydrochloride added on saline infusion media versus 100 mg diclofenac tablet 1 hour before office hysteroscopy , to test their efficacy in reducing pain .

Enrollment

44 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age: 18-35 years.
  • BMI 18.5-30 Kg.
  • Nulliparous women assigned for diagnostic hysteroscopy.
  • Informed written consent.

Exclusion criteria

  • Previous cervical surgery.
  • Cervical stenosis.
  • Known gastritis.
  • Recent or active PID.
  • Cardiac patients.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

44 participants in 2 patient groups

Lidacaine hydrochloride
Experimental group
Description:
Adding 10 ml of 2% Lidocaine hydrochloride on hysteroscopic saline media during office hysteroscopy to test its efficacy in reducing pain. 22 women.
Treatment:
Drug: Lidocaine Hydrochloride
Diclofenac
Active Comparator group
Description:
100 mg Diclofenac oral tablet is administered 1 hour before the procedure to test its efficacy in reducing pain. 22 women.
Treatment:
Drug: Diclofenac

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems